PreveCeutical Medical Company Description

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).

The company is headquartered in West Vancouver, Canada.

PreveCeutical Medical Inc.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
CEO	Stephen Van Deventer

Contact Details

Address: 5428 Marine Drive West Vancouver, British Columbia V7W 2R2 Canada
Phone	604 416 7777
Website	preveceutical.com

Stock Details

Ticker Symbol	PREV
Exchange	Canadian Securities Exchange
Fiscal Year	January - December
Reporting Currency	CAD
ISIN Number	CA74141E1043
SIC Code	2834

Key Executives

Name	Position
Stephen Van Deventer	Chairman, Chief Executive Officer and Chief Financial Officer
Dr. Makarand Jawadekar Ph.D.	Chief Science Officer, President and Director
Dr. Harendra Parekh BSc., Hons I, MRPharmS, Ph.D.	Chief Research Officer
Dr. Francis Tavares	Chief Technology Officer